概要信息：

[{"dir":true,"name":"3/","size":0},{"dir":false,"name":"3/1033 Biological Assay Validation.pdf","size":1249976},{"dir":false,"name":"3/18.差距分析.zip","size":551210},{"dir":false,"name":"3/2.0_GZ-QC-225 CHO-K1-hGPC3细胞复苏、传代和倍增操作.docx","size":218816},{"dir":false,"name":"3/2025版药典与2020版药典差距分析——生化细胞组.xlsx","size":20304},{"dir":false,"name":"3/2025药典差距分析-2025.05.13.xlsx","size":18208},{"dir":false,"name":"3/20260115-WF-B2033 BBA-P.pdf","size":4635992},{"dir":false,"name":"3/44000020250007T89P (2).pdf","size":446408},{"dir":false,"name":"3/AMVP-2024-Q-132Analytical Method Performance Verification Protocol for BGB-B2033 BGB-B2033分析方法性能确认方案.pdf","size":2045741},{"dir":false,"name":"3/AMVP-2025-Q-157 AMVP for Residual Protein A Determination of BG-C477_BG-C477蛋白质A残留量测定方法确认方案.pdf","size":1134071},{"dir":false,"name":"3/AMVP-2025-Q-XXX  BG-XXX生物学活性分析方法确认方案模板.docx","size":187224},{"dir":false,"name":"3/AMVP-2026-Q-011 Analytical Qualification Protocol of BGB-B2033 CBP Assay BGB-B2033生物学活性分析方法确认方案 (1).pdf","size":626479},{"dir":false,"name":"3/AMVP-2026-Q-011 Analytical Qualification Protocol of BGB-B2033 CBP Assay BGB-B2033生物学活性分析方法确认方案.pdf","size":626479},{"dir":false,"name":"3/AMVP-2026-Q-146 BGB-B2033生物学活性分析方法验证方案.pdf","size":825268},{"dir":false,"name":"3/AMVP-2026-Q-180 AMVP for Oligosaccharide Mapping of BGB-B2033BGB-B2033糖基化修饰分析方法验证方案.pdf","size":1325023},{"dir":false,"name":"3/AMVP-2026-Q-280 BON-101生物学活性分析方法确认方案.pdf","size":2344700},{"dir":false,"name":"3/AMVR-2026-Q-011  BGB-B2033生物学活性分析方法确认报告 (1).pdf","size":1470249},{"dir":false,"name":"3/AMVR-2026-Q-011  BGB-B2033生物学活性分析方法确认报告.pdf","size":1470249},{"dir":false,"name":"3/AMVR-2026-Q-089 BG-C477 生产终末细胞无菌检查分析方法确认报告.pdf","size":520868},{"dir":false,"name":"3/Analysis Report of BGB-B2033 MCB BGB-B2033主细胞库分析报告.docx","size":90488}]